Filing Flows › Ensysce Biosciences (ENSC) › Who owns the stock
Who owns Ensysce Biosciences (ENSC) stock
18 funds reported Ensysce Biosciences (ENSC) shares in their latest 13F filings, worth $330K in all. The largest holder is Jane Street Group, LLC ($61K). Last quarter 7 funds added to their stakes and 5 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Jane Street Group, LLC | 208,833 | $61K | increase | 2026-06-30 |
| StoneX Group | 138,563 | $50K | new | 2026-09-30 |
| Adage Capital Partners GP, L.L.C. | 149,711 | $43K | unchanged | 2026-06-30 |
| Vanguard Group | 36,708 | $34K | unchanged | 2025-12-31 |
| Virtu Financial LLC | 95,391 | $28K | increase | 2026-06-30 |
| Perceptive Advisors LLC | 86,666 | $25K | unchanged | 2026-06-30 |
| Citadel Advisors LLC | 86,193 | $25K | increase | 2026-06-30 |
| XTX Topco | 77,005 | $22K | increase | 2026-06-30 |
| Geode Capital Management, LLC | 62,188 | $18K | decrease | 2026-06-30 |
| Susquehanna International Group, LLP | 34,280 | $10K | new | 2026-06-30 |
| TRU Independence Asset Management 2, LLC | 13,000 | $4K | unchanged | 2026-06-30 |
| Two Sigma Securities, LLC | 12,953 | $4K | new | 2026-06-30 |
| Vanguard Capital Management LLC | 12,854 | $4K | unchanged | 2026-06-30 |
| Tower Research Capital LLC | 6,094 | $2K | unchanged | 2026-06-30 |
| FNY Investment Advisers, LLC | 3,000 | $1K | unchanged | 2026-09-30 |
Ensysce Biosciences' latest quarter
Ensysce Biosciences, Q2 2026: revenue $1.2M (-15% year over year), operating margin -221.3%, net loss $2.6M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most ENSC stock?
By the latest 13F filings: Jane Street Group, LLC ($61K); StoneX Group ($50K); Adage Capital Partners GP, L.L.C. ($43K); Vanguard Group ($34K); Virtu Financial LLC ($28K).
What is the short interest in ENSC?
303,956 shares were sold short at the 2026-10-15 settlement, -71.88% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.